Published in Exp Neurol on December 01, 2000
p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells (2010) 2.91
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis Model Mech (2009) 2.16
Lewy bodies. Proc Natl Acad Sci U S A (2006) 2.15
alpha-Synuclein and neuronal cell death. Mol Neurodegener (2009) 1.85
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol (2001) 1.81
Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem (2010) 1.69
Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders. Acta Neuropathol (2010) 1.63
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol (2002) 1.54
Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. J Neurosci (2010) 1.46
The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding. Biophys J (2010) 1.39
Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat (2007) 1.08
Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol (2009) 1.06
α-synuclein, LRRK2 and their interplay in Parkinson's disease. Future Neurol (2012) 0.97
Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS One (2011) 0.96
Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Mol Neurodegener (2009) 0.95
Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies. Am J Pathol (2002) 0.95
Mitochondrial dysfunction in Parkinson's disease. Parkinsons Dis (2011) 0.93
A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci (2015) 0.92
Seeking a mechanism for the toxicity of oligomeric α-synuclein. Biomolecules (2015) 0.88
Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation. Transl Neurodegener (2012) 0.87
Regulation of Weibel-Palade body exocytosis by alpha-synuclein in endothelial cells. J Biol Chem (2010) 0.87
Radiating amyloid fibril formation on the surface of lipid membranes through unit-assembly of oligomeric species of α-synuclein. PLoS One (2012) 0.84
Membrane lipid co-aggregation with α-synuclein fibrils. PLoS One (2013) 0.83
NMR structure of calmodulin complexed to an N-terminally acetylated α-synuclein peptide. Biochemistry (2013) 0.83
Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. J Neural Transm (Vienna) (2005) 0.82
Copper-triggered aggregation of ubiquitin. PLoS One (2009) 0.82
Amyloids of alpha-synuclein affect the structure and dynamics of supported lipid bilayers. Biophys J (2014) 0.81
Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis. Am J Pathol (2003) 0.81
Functionally different α-synuclein inclusions yield insight into Parkinson's disease pathology. Sci Rep (2016) 0.80
APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease. Neurol Sci (2014) 0.79
Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein. Biochim Biophys Acta (2016) 0.78
Fenpropathrin, a Widely Used Pesticide, Causes Dopaminergic Degeneration. Mol Neurobiol (2015) 0.76
Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design. Interface Focus (2017) 0.75
Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity. Biomed Res Int (2016) 0.75
Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice. Life Sci (2012) 0.75
From the Cover: Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease Models. Toxicol Sci (2016) 0.75
Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes. Mitochondrion (2014) 0.75
Gaucher-Associated Parkinsonism. Cell Mol Neurobiol (2015) 0.75
Glucocerebrosidase and parkinsonism: lessons to learn. J Neurol (2016) 0.75
Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A (1991) 4.78
HITS: a short domestic violence screening tool for use in a family practice setting. Fam Med (1998) 1.97
Effect of global system for mobile communication (gsm)-like radiofrequency fields on vascular permeability in mouse brain. Pathology (2001) 1.75
The role and regulation of tumour-associated hyaluronan. Ciba Found Symp (1989) 1.68
SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol (2003) 1.66
Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain. Eur J Pain (2012) 1.61
Bronchopulmonary infection due to Branhamella catarrhalis. Br Med J (Clin Res Ed) (1983) 1.50
Branhamella catarrhalis prevalence in a hospital population. J Hosp Infect (1985) 1.40
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol (1990) 1.37
Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med (1990) 1.30
Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene (1998) 1.29
The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. J Neurochem (2001) 1.29
Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res (1990) 1.28
Traumatic brain injury. Vet Pathol (2002) 1.28
Brain weights in alcoholics. J Neurol Neurosurg Psychiatry (1982) 1.26
The three-dimensional structure of the first domain of neural cell adhesion molecule. Nat Struct Biol (1996) 1.20
Critical biological determinants of incorporation of non-vascularized cortical bone grafts. Quantification of a complex process and structure. J Bone Joint Surg Am (1997) 1.19
Multiple-system atrophy: a new alpha-synuclein disease? Lancet (1998) 1.18
Multiple copies of virG enhance the transient transformation of celery, carrot and rice tissues by Agrobacterium tumefaciens. Plant Mol Biol (1992) 1.17
Nuclear genes associated with a single Brassica CMS restorer locus influence transcripts of three different mitochondrial gene regions. Genetics (1996) 1.16
Brassica nap cytoplasmic male sterility is associated with expression of a mtDNA region containing a chimeric gene similar to the pol CMS-associated orf224 gene. Curr Genet (1997) 1.14
Crevice corrosion of cemented titanium alloy stems in total hip replacements. Clin Orthop Relat Res (1996) 1.12
Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem (1999) 1.12
Erythromycin in the management of troublesome BCG lesions. Br J Dis Chest (1984) 1.10
Interstitial deletion 1p as a result of a de novo reciprocal 1p;2p translocation. Ann Genet (1985) 1.09
Nocturnal cough in patients with chronic bronchitis and emphysema. Am Rev Respir Dis (1984) 1.09
Cleavage specificity of chloroplast and nuclear tRNA 3'-processing nucleases. Mol Cell Biol (1992) 1.06
Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. Phys Rev Lett (2013) 1.05
Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. J Biol Chem (2001) 1.04
The neuropathology of melioidosis: two cases and a review of the literature. Clin Neuropathol (2004) 1.02
Observation of electron-antineutrino disappearance at Daya Bay. Phys Rev Lett (2012) 1.00
Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis. Scand J Gastroenterol (1986) 0.99
Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp Neurol (1999) 0.98
The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis. Cell Death Differ (1998) 0.96
The fate of cancellous and cortical bone after transplantation of fresh and frozen tissue-antigen-matched and mismatched osteochondral allografts in dogs. J Bone Joint Surg Am (1991) 0.95
Paranodal pathology in Tangier disease with remitting-relapsing multifocal neuropathy. J Clin Neurosci (2006) 0.95
The pathologic effects of intrathecal betamethasone. Spine (Phila Pa 1976) (1997) 0.95
[Primary anterior dislocation of the shoulder. A follow-up study of patients under 50 years]. Ugeskr Laeger (1986) 0.95
Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor. FEBS Lett (1994) 0.94
Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin. J Comp Pathol (1999) 0.94
Neoplastic cerebral aneurysm from metastatic gestational choriocarcinoma. Case report. J Neurosurg (1985) 0.94
Acute effects of noradrenalin related vasoactive agents on the ototoxicity of aspirin: an experimental study in the guinea pig. Hear Res (1988) 0.93
Vasculitis of peripheral nerve and skeletal muscle: clinicopathological correlation and immunopathic mechanisms. J Neurol Sci (1990) 0.92
Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance. J Oral Pathol Med (2008) 0.91
Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochem J (1994) 0.91
Primary (granulomatous) angiitis of the central nervous system with multiple aneurysms of spinal arteries. Case report. J Neurosurg (1993) 0.91
Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma. Thorax (1987) 0.90
Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol (2001) 0.90
Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans (2003) 0.90
Age-related loss of dorsal vagal neurons in Parkinson's disease. Neurology (1992) 0.90
Immunosuppressive properties of electrophoretically "slow" and "fast" form alpha 2-macroglobulin. Effects on cell-mediated cytotoxicity and (allo-) antigen-induced T cell proliferation. J Immunol (1989) 0.89
Malignant melanoma metastatic to a meningioma. Pathology (1999) 0.89
Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain (1995) 0.89
Identification of a neuritogenic ligand of the neural cell adhesion molecule using a combinatorial library of synthetic peptides. Nat Biotechnol (1999) 0.89
Clinical features of mitochondrial myopathy. Aust N Z J Med (1983) 0.87
Polymyositis presenting with respiratory failure. J Neurol Sci (1984) 0.87
alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol (2003) 0.87
Excitotoxic model of post-traumatic syringomyelia in the rat. Spine (Phila Pa 1976) (2001) 0.87
First observation of the M1 transition ψ(3686)→γη(c)(2S). Phys Rev Lett (2012) 0.86
Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies. FEBS Lett (1991) 0.86
Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. Brain (1991) 0.86
Comparison of quantitative trait loci controlling seedling characteristics at two seedling stages using rice recombinant inbred lines. Theor Appl Genet (2004) 0.86
Fulminant leucocytoclastic brainstem vasculitis in a patient with otherwise indolent systemic lupus erythematosus. Lupus (2009) 0.85
Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res (2005) 0.85
Observation of two new N* resonances in the decay ψ(3686)→ppπ0. Phys Rev Lett (2013) 0.85
Brain injury patterns in fatally injured pedestrians. J Trauma (1994) 0.84
Spatial distribution and vertical variation of arsenic in Guangdong soil profiles, China. Environ Pollut (2006) 0.84
SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett (2005) 0.83
Organochlorine pesticide residuals in chickens and eggs at a poultry farm in Beijing, China. Environ Pollut (2008) 0.83
Central core disease. Study of a family with five affected generations. J Neurol Sci (1982) 0.83
Haemangiopericytoma presenting as recurrent intracranial haemorrhage. J Clin Neurosci (1997) 0.83
First observation of η(1405) decays into f(0)(980)π0. Phys Rev Lett (2012) 0.83
Ketotifen and nocturnal asthma. Thorax (1983) 0.83
Cerebral malakoplakia. J Clin Pathol (1981) 0.83
Patterns of immunocytochemical staining for ferritin and transferrin in the human spinal cord following traumatic injury. J Clin Neurosci (2002) 0.83
Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci (1998) 0.82
Intracranial haemorrhage from meningiomas: a report of five cases. Br J Neurosurg (1989) 0.82
Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid. Brain Res Mol Brain Res (1997) 0.82
Pathogenic significance of Klebsiella oxytoca in acute respiratory tract infection. Thorax (1983) 0.82
Toxin-induced vasogenic cerebral oedema in a rat model. Acta Neurochir Suppl (2000) 0.82
Developmental regulation of tissue transglutaminase during human placentation and expression in neoplastic trophoblast. J Pathol (1997) 0.82
Primary empty sella turcica: a radiological-anatomical correlation. Australas Radiol (2000) 0.82
Multiple cerebral arteriovenous malformations associated with soft-tissue vascular malformations. Case report. J Neurosurg (1981) 0.82
Increased substance P immunoreactivity and edema formation following reversible ischemic stroke. Acta Neurochir Suppl (2006) 0.82
Choroid plexus arteriovenous malformations. A report of four pathologically proven cases and review of the literature. Br J Neurosurg (1996) 0.82
Correlation of postmortem MRI and CT appearances with neuropathology in brain trauma: a comparison of two methods. J Clin Neurosci (1998) 0.81
Hypotensive central infarction of the spinal cord. J Neurol Neurosurg Psychiatry (1980) 0.81
Brain infarction in young men. Clin Exp Neurol (1979) 0.81
Circadian and septadian variation in the occurrence of acute myocardial infarction in a Chinese population. Jpn Circ J (1998) 0.81
Pattern of cerebrospinal immediate early gene c-fos expression in an ovine model of non-accidental head injury. J Clin Neurosci (2013) 0.81
Topographical uptake of blood-borne horseradish peroxidase (HRP) in the murine testis at the light microscopic level. Int J Androl (1998) 0.80
Substantia nigra degeneration in motor neurone disease: a quantitative study. Aust N Z J Med (1992) 0.80
Axonal injury in falls. J Neurotrauma (1997) 0.80
p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event. Clin Mol Pathol (1995) 0.80
A Rosenthal fiber encephalomyelopathy resembling Alexander's disease in 3 sheep. Vet Pathol (2011) 0.79
Observation of a near-threshold enhancement in the pp mass spectrum from radiative J/psi-->gammapp decays. Phys Rev Lett (2003) 0.79
Fat embolism syndrome with total hip replacement. Med J Aust (1986) 0.79